These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 14967820)
1. Fatty liver in familial hypobetalipoproteinemia: roles of the APOB defects, intra-abdominal adipose tissue, and insulin sensitivity. Tanoli T; Yue P; Yablonskiy D; Schonfeld G J Lipid Res; 2004 May; 45(5):941-7. PubMed ID: 14967820 [TBL] [Abstract][Full Text] [Related]
2. Absence of fatty liver in familial hypobetalipoproteinemia linked to chromosome 3p21. Yue P; Tanoli T; Wilhelm O; Patterson B; Yablonskiy D; Schonfeld G Metabolism; 2005 May; 54(5):682-8. PubMed ID: 15877300 [TBL] [Abstract][Full Text] [Related]
3. Fatty liver in familial hypobetalipoproteinemia: triglyceride assembly into VLDL particles is affected by the extent of hepatic steatosis. Schonfeld G; Patterson BW; Yablonskiy DA; Tanoli TS; Averna M; Elias N; Yue P; Ackerman J J Lipid Res; 2003 Mar; 44(3):470-8. PubMed ID: 12562873 [TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein B gene mutations and fatty liver in Japanese hypobetalipoproteinemia. Katsuda S; Kawashiri MA; Inazu A; Tada H; Tsuchida M; Kaneko Y; Nozue T; Nohara A; Okada T; Kobayashi J; Michishita I; Mabuchi H; Yamagishi M Clin Chim Acta; 2009 Jan; 399(1-2):64-8. PubMed ID: 18848826 [TBL] [Abstract][Full Text] [Related]
5. Familial hypobetalipoproteinemia: genetics and metabolism. Schonfeld G; Lin X; Yue P Cell Mol Life Sci; 2005 Jun; 62(12):1372-8. PubMed ID: 15818469 [TBL] [Abstract][Full Text] [Related]
6. Decreased production rates of VLDL triglycerides and ApoB-100 in subjects heterozygous for familial hypobetalipoproteinemia. Elias N; Patterson BW; Schonfeld G Arterioscler Thromb Vasc Biol; 1999 Nov; 19(11):2714-21. PubMed ID: 10559016 [TBL] [Abstract][Full Text] [Related]
8. A targeted apoB38.9 mutation in mice is associated with reduced hepatic cholesterol synthesis and enhanced lipid peroxidation. Lin X; Chen Z; Yue P; Averna MR; Ostlund RE; Watson MA; Schonfeld G Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1170-6. PubMed ID: 16455790 [TBL] [Abstract][Full Text] [Related]
9. Fatty liver and insulin resistance in children with hypobetalipoproteinemia: the importance of aetiology. Della Corte C; Fintini D; Giordano U; Cappa M; Brufani C; Majo F; Mennini C; Nobili V Clin Endocrinol (Oxf); 2013 Jul; 79(1):49-54. PubMed ID: 22789032 [TBL] [Abstract][Full Text] [Related]
10. Hepatosteatosis with hypobetalipoproteinemia. Sen D; Dagdelen S; Erbas T J Natl Med Assoc; 2007 Mar; 99(3):284-6. PubMed ID: 17393954 [TBL] [Abstract][Full Text] [Related]
11. Reduced intestinal fat absorptive capacity but enhanced susceptibility to diet-induced fatty liver in mice heterozygous for ApoB38.9 truncation. Lin X; Yue P; Xie Y; Davidson NO; Sakata N; Ostlund RE; Chen Z; Schonfeld G Am J Physiol Gastrointest Liver Physiol; 2005 Jul; 289(1):G146-52. PubMed ID: 15790761 [TBL] [Abstract][Full Text] [Related]
12. [Homozygous familial hypobetalipoproteinemia caused by APOB gene variations: a case report and review of literature]. Zhang YQ; Wang JS Zhonghua Er Ke Za Zhi; 2023 Jan; 61(1):70-75. PubMed ID: 36594125 [No Abstract] [Full Text] [Related]
13. Fatty liver and insulin resistance: not always linked. Schonfeld G; Yue P; Lin X; Chen Z Trans Am Clin Climatol Assoc; 2008; 119():217-23; discussion 223-4. PubMed ID: 18596860 [TBL] [Abstract][Full Text] [Related]
14. A study of fatty liver disease and plasma lipoproteins in a kindred with familial hypobetalipoproteinemia due to a novel truncated form of apolipoprotein B (APO B-54.5). Tarugi P; Lonardo A; Ballarini G; Erspamer L; Tondelli E; Bertolini S; Calandra S J Hepatol; 2000 Sep; 33(3):361-70. PubMed ID: 11019990 [TBL] [Abstract][Full Text] [Related]
16. A targeted apolipoprotein B-38.9-producing mutation causes fatty livers in mice due to the reduced ability of apolipoprotein B-38.9 to transport triglycerides. Chen Z; Fitzgerald RL; Averna MR; Schonfeld G J Biol Chem; 2000 Oct; 275(42):32807-15. PubMed ID: 10893242 [TBL] [Abstract][Full Text] [Related]
17. Homozygous MTTP and APOB mutations may lead to hepatic steatosis and fibrosis despite metabolic differences in congenital hypocholesterolemia. Di Filippo M; Moulin P; Roy P; Samson-Bouma ME; Collardeau-Frachon S; Chebel-Dumont S; Peretti N; Dumortier J; Zoulim F; Fontanges T; Parini R; Rigoldi M; Furlan F; Mancini G; Bonnefont-Rousselot D; Bruckert E; Schmitz J; Scoazec JY; Charrière S; Villar-Fimbel S; Gottrand F; Dubern B; Doummar D; Joly F; Liard-Meillon ME; Lachaux A; Sassolas A J Hepatol; 2014 Oct; 61(4):891-902. PubMed ID: 24842304 [TBL] [Abstract][Full Text] [Related]
18. Familial hypobetalipoproteinemia in a hospital survey: genetics, metabolism and non-alcoholic fatty liver disease. Gutiérrez-Cirlos C; Ordóñez-Sánchez ML; Tusié-Luna MT; Patterson BW; Schonfeld G; Aguilar-Salinas CA Ann Hepatol; 2011; 10(2):155-64. PubMed ID: 21502677 [TBL] [Abstract][Full Text] [Related]
19. Four novel mutations in APOB causing heterozygous and homozygous familial hypobetalipoproteinemia. Whitfield AJ; Marais AD; Robertson K; Barrett PH; van Bockxmeer FM; Burnett JR Hum Mutat; 2003 Aug; 22(2):178. PubMed ID: 12872264 [TBL] [Abstract][Full Text] [Related]
20. Non-alcoholic steatohepatitis-related cirrhosis in a patient with APOB L343V familial hypobetalipoproteinaemia. Heeks LV; Hooper AJ; Adams LA; Robbins P; Barrett PH; van Bockxmeer FM; Burnett JR Clin Chim Acta; 2013 Jun; 421():121-5. PubMed ID: 23694813 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]